A detailed history of Coston, Mc Isaac & Partners transactions in Takeda Pharmaceutical CO LTD stock. As of the latest transaction made, Coston, Mc Isaac & Partners holds 259 shares of TAK stock, worth $3,411. This represents 0.0% of its overall portfolio holdings.

Number of Shares
259
Previous 259 -0.0%
Holding current value
$3,411
Previous $3,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 17, 2024

SELL
$13.89 - $15.04 $97 - $105
-7 Reduced 2.63%
259 $3,000
Q2 2022

Sep 21, 2022

BUY
$13.12 - $15.03 $3,489 - $3,997
266 New
266 $4,000

Others Institutions Holding TAK

About TAKEDA PHARMACEUTICAL CO LTD


  • Ticker TAK
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 3,109,050,112
  • Market Cap $40.9B
  • Description
  • Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...
More about TAK
Track This Portfolio

Track Coston, Mc Isaac & Partners Portfolio

Follow Coston, Mc Isaac & Partners and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Coston, Mc Isaac & Partners, based on Form 13F filings with the SEC.

News

Stay updated on Coston, Mc Isaac & Partners with notifications on news.